Results 141 to 150 of about 208,047 (254)

Changes of pupil parameters and visual quality after cataract surgery as well as their correlation. [PDF]

Int J Ophthalmol
Yang F, Xu J, Lin PM, Wang MY, Zheng TY.
europepmc   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Anterior corneal contribution to peripheral aberrations of human eyes

, 2004
Anterior corneal and internal component contributions to overall peripheral aberrations of five human eyes were determined, based on corneal topography and overall aberration measurements.
Atchison, David A.
core  

Establishing a precision reference benchmark for corneal epithelial aberration measurements using a new hybrid device across keratoconus stages. [PDF]

Eye Vis (Lond)
Yang Y, Ning R, Li S, Yang X, Wang Y, Li K, Savini G, Schiano-Lomoriello D, Zhou X, Huang J.   +9 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Aberration correction and complementary beam subtraction in light-sheet fluorescence microscopy. [PDF]

J Biomed Opt
Zhang Y, Yang R, Li X, Dan D, Yang Y, Liu Y, Li R, Qian J, Dai T, Kong L, Yu X, Yao B.   +11 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Radiotherapy Technique Determines the Magnitude and Persistence of T-Lymphocyte DNA Damage. [PDF]

Cancers (Basel)
Kocsis ZS, Ágoston P, Farkas G, Székely G, Sándor GO, Jorgo K, Gesztesi L, Major T, Pesznyák C, Herein A, Stelczer G, Mihály D, Fröhlich G, Takácsi-Nagy Z, Polgár C, Jurányi Z.   +15 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Baseline Frequency of Chromosomal Aberrations in Control Donors: A Significant Value for Population Monitoring During the Development of the Nuclear Energy Industry-Polish Dataset. [PDF]

Toxics
Sommer S, Buraczewska I, Korzeniowska-Sobczuk A, Sikorska K.   +3 more
europepmc   +1 more source